On September 7, 2022 Citius Pharmaceuticals, Inc. ("Citius" or the "Company") ( Nasdaq: CTXR), reported that Citius will participate in the H.C. Wainwright 24th Annual Global Investment Conference being held September 12-14, 2022 (Press release, Citius Pharmaceuticals, SEP 7, 2022, https://www.prnewswire.com/news-releases/citius-pharmaceuticals-inc-to-present-at-the-hc-wainwright-24th-annual-global-investment-conference-301619139.html [SID1234619214]). Leonard Mazur, Chairman and CEO of Citius, will present in person on September 14, 2022 at 11:00am EDT, and host one-on-one meetings with investors.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Registered participants will be able to view Mr. Mazur’s presentation live through the conference website or access an archived webcast of the presentation under "Events" in the Investors section of the Citius website. The archived webcast will be available for 90 days following the event.